Hepatic function of glucagon-like peptide-1 and its based diabetes drugs por Walter Suárez Carmona | Ene 22, 2025
Is glycaemic control still central in the hierarchy of priorities in type 2 diabetes management? The way forward is to combine glucose control and the prevention of cardiorenal complications por Walter Suárez Carmona | Ene 22, 2025
Glucagon-like peptide receptor-1 receptor agonists: The emerging fourth pillar in type 2 diabetes and chronic kidney disease? por Walter Suárez Carmona | Ene 22, 2025
Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes por Walter Suárez Carmona | Ene 22, 2025
Emerging role of incretin-based therapy as first-line antihypertensives in obesity por Walter Suárez Carmona | Ene 22, 2025
